ArticleOphthalmology2026
Diagnostic Utility of Paton's Folds and Quantitative OCT Metrics in Pediatric Papilledema.
Article in Ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeWe evaluated the diagnostic accuracy of peripapillary retinal folds (RFs) and peripapillary wrinkling (PPW) in distinguishing papilledema (PE) from pseudopapilledema (PPE) in pediatric patients using spectral-domain OCT (SD-OCT). We also identified diagnostic threshold values for retinal nerve fiber layer (RNFL) thickness and optic nerve head volume (ONHV).
designSingle-center, hospital and clinic-based, retrospective, cross-sectional study.
participantsWe included 84 eyes from 42 pediatric patients with PE and 92 eyes from 46 pediatric patients with PPE.
methodsTwo masked ophthalmologists (H.V. and D.R.) independently reviewed transverse and en face SD-OCT images to assess for RF and PPW. We manually segmented retinal layers and measured RNFL thickness and ONHV. We performed receiver operating curve (ROC) analysis with area under the curve (AUC) to determine optimal diagnostic thresholds. We assessed inter-rater reliability using Cohen's kappa.
main outcome measuresSensitivity and specificity for RF and PPW; optimal diagnostic thresholds for RNFL and ONHV in distinguishing PE from PPE in pediatric patients.
resultsWe observed RFs or PPW in 90.2% of PE eyes and 38.6% of PPE eyes (P < 0.0001). Retinal folds demonstrated higher sensitivity (79.2%) but lower specificity (67.4%), whereas PPW showed higher specificity (92.9%) and lower sensitivity (43.5%) in distinguishing PE from PPE in pediatric patients. Transverse OCT had the highest probability of detecting RFs as a marker for PE, whereas en face OCT was more reliable at detecting PPW. Receiver operating characteristic analysis identified optimal PE screening thresholds of ≥163 μm for RNFL (AUC = 0.908) with 78% sensitivity and 93% specificity and a threshold of ≥5.43 mm
conclusionsPeripapillary wrinkling is specific to PE in pediatric patients and an excellent rule-in tool. Transverse SD-OCT reliably detects Paton's folds, particularly RF. However, the limited specificity of RF and higher inter-rater variability of rare, subtle findings underscore the importance of incorporating quantitative OCT metrics. Retinal nerve fiber layer thickness and ONHV offer strong discriminative power and objective thresholds to support clinical decision-making. In borderline cases, clinicians can improve diagnostic confidence by integrating fold detection with RNFL and ONHV analysis, additional ancillary testing, and clinical history with exam to create a more accurate, noninvasive approach to distinguish PE from PPE in children. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.